A randomized, pharmacodynamic comparison of low dose ticagrelor (60mg bid) to low dose prasugrel (5mg od) in patients with prior myocardial infarction: the ALTIC-2 study

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Antiplatelet therapy Antiplatelet Drugs ESC Premium Access ESC Congress 2019

About the speaker

Photo

Guy's and St Thomas' NHS Trust Hospitals, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Doctor D. Errigo (Turin, IT)
Presentation thumbnail
Doctor J. Li (Beijing, CN)
Presentation thumbnail
Doctor D. Cosmi (Perugia, IT)
Presentation thumbnail
Assistant Professor F. Ricci (Chieti, IT)

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET

ESC 365 is supported by

ESC 365 is supported by